Zobrazeno 1 - 7
of 7
pro vyhledávání: '"C. A. Hanzis"'
Autor:
Lian Xu, Sigitas Verselis, Hsiuyi Tseng, Robert Manning, Leukothea Ioakimidis, Steven P. Treon, C. A. Hanzis, Zachary R. Hunter, Barry Turnbull, Patricia Sheehy, Christopher J. Patterson, Guang Yang, Edward A. Fox
Publikováno v:
British Journal of Haematology. 154:223-228
The incorporation of rituximab into various regimens has improved depth of response in Waldenstrom macroglobulinaemia (WM), though the impact of achieving better responses remains to be determined. We examined response depth on progression-free survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5068adb7ee0641de9f4ee179ae9de68c
https://doi.org/10.1111/j.1365-2141.2011.08726.x
https://doi.org/10.1111/j.1365-2141.2011.08726.x
Autor:
Lian Xu, C. A. Hanzis, Ping Gong, Bryan Ciccarelli, Leukothea Ioakimidis, Steven P. Treon, Hsuiyi Tseng, Christopher J. Patterson, Xia Liu, Jenny Sun, Massimo Morra, Megan Lewicki, Robert Manning, Zachary R. Hunter, Guang Yang, Patricia Sheehy, Yangsheng Zhou
Background Hypogammaglobulinemia is common in Waldenstrom’s macroglobulinemia. The etiology of this finding remains unclear, but it has been speculated to be based on tumor-induced suppression of the ‘uninvolved’ immunoglobulin productionDesign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59373cf5a74cb807ba75b5bdde869949
https://europepmc.org/articles/PMC2833078/
https://europepmc.org/articles/PMC2833078/
Autor:
Christina K. Tripsas, Steven P. Treon, Zachary R. Hunter, Patricia Sheehy, Leukothea Ioakimidis, C. A. Hanzis, C. J. Patterson, Barry Turnbull, Robert Manning
Publikováno v:
Journal of Clinical Oncology. 29:8073-8073
8073 Background: Previous studies by us and others support a familial predisposition in certain patients with Waldenstrom’s Macroglobulinemia (WM). The incidence, as well as clinical implications f...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b53faab78220a74ced62d1e5bf2a2e37
https://doi.org/10.1200/jco.2011.29.15_suppl.8073
https://doi.org/10.1200/jco.2011.29.15_suppl.8073
Autor:
M. J. Felini, Zachary R. Hunter, Raymond Thertulien, C. A. Hanzis, L. M. Brown Philpot, Steven P. Treon, Rohit P. Ojha
Publikováno v:
Journal of Clinical Oncology. 29:e18566-e18566
e18566 Background: Waldenstrom Macroglobulinemia (WM) is a rare and indolent B-cell malignancy characterized by overproduction of monoclonal immunoglobulin M protein. The long duration of survival ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3fd84858e096acda36bf5534dced2a4
https://doi.org/10.1200/jco.2011.29.15_suppl.e18566
https://doi.org/10.1200/jco.2011.29.15_suppl.e18566
Autor:
Patricia Sheehy, Zachary R. Hunter, Robert Manning, C. J. Patterson, P. S. Brodsky, Leukothea Ioakimidis, C. A. Hanzis, Steven P. Treon
Publikováno v:
Journal of Clinical Oncology. 28:8114-8114
8114 Background: Peripheral neuropathy (PN) is a debilitating morbidity in WM, whose natural history and treatment outcome is largely unknown. Methods: We examined the incidence, characteristics, a...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ec050af7ccf2a0e91a9e87abd0d23f5
https://doi.org/10.1200/jco.2010.28.15_suppl.8114
https://doi.org/10.1200/jco.2010.28.15_suppl.8114
Autor:
P. Gong, C. J. Patterson, Steven P. Treon, Lian Xu, Leukothea Ioakimidis, C. A. Hanzis, Guang Yang, Patricia Sheehy, Robert Manning, Zachary R. Hunter
Publikováno v:
Journal of Clinical Oncology. 28:8108-8108
8108 Background: The incorporation of rituximab into various regimens has improved depth of response in Waldenstrom's macroglobulinemia (WM), though the impact of achieving better responses remains...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de38d5fbb6227bf521b7aaf6bf4d4dee
https://doi.org/10.1200/jco.2010.28.15_suppl.8108
https://doi.org/10.1200/jco.2010.28.15_suppl.8108
Autor:
Barry Turnbull, Steven P. Treon, C. A. Hanzis, C. J. Patterson, Robert Manning, Patricia Sheehy, P. S. Brodsky, Leukothea Ioakimidis, Jacob D. Soumerai, Zachary R. Hunter
Publikováno v:
Journal of Clinical Oncology. 28:8107-8107
8107 Background: Rituximab alone and in combination is an important mainstay of therapy for WM. While maintenance rituximab (MRx) is often employed after induction therapy, its safety and efficacy ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5512cccf6ce9cd8d94983bd686d4df62
https://doi.org/10.1200/jco.2010.28.15_suppl.8107
https://doi.org/10.1200/jco.2010.28.15_suppl.8107